Literature DB >> 6189603

Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.

G M Mead, J A Green, F R Macbeth, C J Williams, J M Whitehouse, R Buchanan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6189603

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  4 in total

1.  Carcinogenic effect of cisplatin (cis-diammine-dichloroplatinum (II), CDDP) in BD IX rats.

Authors:  S R Kempf; S Ivankovic
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

2.  Protein binding, sister chromatid exchange and expression of oncogene proteins in patients treated with cisplatinum (cisDDP)-based chemotherapy.

Authors:  F Perera; H K Fischman; K Hemminki; P Brandt-Rauf; H L Niman; S Smith; E Toporoff; K O'Dowd; M X Tang; W Y Tsai
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

3.  Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.

Authors:  E Reed; S H Yuspa; L A Zwelling; R F Ozols; M C Poirier
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

4.  Polyclonal antibodies to quantitate cis-diamminedichloroplatinum(II)--DNA adducts in cancer patients and animal models.

Authors:  M C Poirier; E Reed; L A Zwelling; R F Ozols; C L Litterst; S H Yuspa
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.